Time trends in oral bisphosphonate initiation in Ontario, Canada over 20 years reflect drug policy and healthcare delivery changes
ConclusionsThe characteristics of patients starting oral bisphosphonate therapy have changed over time. Consideration must be given to these time trends when designing studies that examine osteoporosis drug effects.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research
More News: Actonel | Canada Health | Cholesterol | Diabetes | Endocrinology | Hormone Replacement Therapy | Hormones | Orthopaedics | Osteoporosis | Risedronate | Statin Therapy | Study | Women